VY BlackRock Health Sciences Opps S
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
N/A
1 yr return
33.6%
3 Yr Avg Return
21.2%
5 Yr Avg Return
19.9%
Net Assets
$455 M
Holdings in Top 10
29.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.00%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 88.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
IEHSX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return 21.2%
- 5 Yr Annualized Total Return 19.9%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.39%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameVY BlackRock Health Sciences Opportunities Portfolio
-
Fund Family NameVoya
-
Inception DateMay 03, 2004
-
Shares OutstandingN/A
-
Share ClassS
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerErin Xie
Fund Description
IEHSX - Performance
Return Ranking - Trailing
Period | IEHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -50.0% | 268.1% | N/A |
1 Yr | 33.6% | -64.8% | 268.1% | N/A |
3 Yr | 21.2%* | -100.0% | 115.6% | N/A |
5 Yr | 19.9%* | -100.0% | 58.6% | N/A |
10 Yr | 9.8%* | -12.1% | 26.2% | N/A |
* Annualized
Return Ranking - Calendar
Period | IEHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -100.0% | 73.0% | N/A |
2022 | N/A | -76.0% | 212.6% | N/A |
2021 | N/A | -65.0% | 900.0% | N/A |
2020 | N/A | -87.3% | 336.8% | N/A |
2019 | N/A | -60.1% | 304.1% | N/A |
Total Return Ranking - Trailing
Period | IEHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -50.0% | 268.1% | N/A |
1 Yr | 33.6% | -64.8% | 268.1% | N/A |
3 Yr | 21.2%* | -100.0% | 115.6% | N/A |
5 Yr | 19.9%* | -100.0% | 58.6% | N/A |
10 Yr | 9.8%* | -12.1% | 26.3% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | IEHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -100.0% | 76.6% | N/A |
2022 | N/A | -30.7% | 212.6% | N/A |
2021 | N/A | -65.0% | 900.0% | N/A |
2020 | N/A | -87.3% | 341.1% | N/A |
2019 | N/A | -60.1% | 304.1% | N/A |
IEHSX - Holdings
Concentration Analysis
IEHSX | Category Low | Category High | IEHSX % Rank | |
---|---|---|---|---|
Net Assets | 455 M | 10 | 804 B | N/A |
Number of Holdings | 120 | 1 | 17333 | N/A |
Net Assets in Top 10 | 136 M | -7.11 B | 145 B | N/A |
Weighting of Top 10 | 29.65% | 0.0% | 20474.3% | N/A |
Top 10 Holdings
- Johnson & Johnson 3.99%
- Biogen Idec Inc 3.82%
- Pfizer Inc 3.46%
- Merck & Co Inc 3.19%
- AbbVie Inc 3.02%
- Alexion Pharmaceuticals Inc 2.58%
- Bayer AG 2.55%
- Celgene Corp 2.49%
- UnitedHealth Group Inc 2.34%
- Covidien PLC 2.22%
Asset Allocation
Weighting | Return Low | Return High | IEHSX % Rank | |
---|---|---|---|---|
Stocks | 90.07% | -142.98% | 259.25% | N/A |
Other | 6.93% | -7288.76% | 493.15% | N/A |
Cash | 3.00% | -2458.20% | 7388.76% | N/A |
Preferred Stocks | 0.00% | -21.20% | 80.89% | N/A |
Convertible Bonds | 0.00% | -0.37% | 144.58% | N/A |
Bonds | 0.00% | -955.59% | 2458.15% | N/A |
Stock Sector Breakdown
Weighting | Return Low | Return High | IEHSX % Rank | |
---|---|---|---|---|
Healthcare | 88.29% | -15.38% | 100.00% | N/A |
Technology | 1.01% | -26.81% | 99.57% | N/A |
Basic Materials | 0.49% | -5.18% | 96.19% | N/A |
Consumer Cyclical | 0.27% | -20.80% | 87.44% | N/A |
Utilities | 0.00% | -3.80% | 94.95% | N/A |
Real Estate | 0.00% | -8.52% | 100.26% | N/A |
Industrials | 0.00% | -19.53% | 93.31% | N/A |
Financial Services | 0.00% | -7.59% | 99.69% | N/A |
Energy | 0.00% | -6.25% | 144.83% | N/A |
Communication Services | 0.00% | -9.27% | 90.02% | N/A |
Consumer Defense | 0.00% | -7.54% | 98.24% | N/A |
Stock Geographic Breakdown
Weighting | Return Low | Return High | IEHSX % Rank | |
---|---|---|---|---|
US | 76.33% | -142.98% | 149.27% | N/A |
Non US | 13.74% | -38.73% | 159.65% | N/A |
IEHSX - Expenses
Operational Fees
IEHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.00% | -2.86% | 950.64% | N/A |
Management Fee | 0.75% | 0.00% | 2.87% | N/A |
12b-1 Fee | 0.25% | 0.00% | 1.00% | N/A |
Administrative Fee | 0.10% | 0.00% | 52000.00% | N/A |
Sales Fees
IEHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 25.00% | N/A |
Deferred Load | N/A | 0.25% | 5.50% | N/A |
Trading Fees
IEHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 0.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
IEHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 88.00% | 0.00% | 5067.00% | N/A |
IEHSX - Distributions
Dividend Yield Analysis
IEHSX | Category Low | Category High | IEHSX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 84.51% | N/A |
Dividend Distribution Analysis
IEHSX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Monthly | Annually |
Net Income Ratio Analysis
IEHSX | Category Low | Category High | IEHSX % Rank | |
---|---|---|---|---|
Net Income Ratio | 0.39% | -46.00% | 10.88% | N/A |
Capital Gain Distribution Analysis
IEHSX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Jul 18, 2014 | $0.069 | |
Jul 17, 2013 | $0.009 | |
Jul 17, 2012 | $0.094 | |
Jul 15, 2011 | $0.057 | |
Jul 17, 2008 | $0.017 | |
Jul 05, 2007 | $0.017 | |
Dec 20, 2005 | $0.001 |
IEHSX - Fund Manager Analysis
Managers
Erin Xie
Start Date
Tenure
Tenure Rank
May 01, 2011
3.17
3.2%
Xie is the managing director and Portfolio Manager of BlackRock Advisor. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.
Thomas P. Callan
Start Date
Tenure
Tenure Rank
May 01, 2011
3.17
3.2%
Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.01 | 33.52 | 5.37 | 3.25 |